BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18172301)

  • 1. Twist promotes tumor cell growth through YB-1 expression.
    Shiota M; Izumi H; Onitsuka T; Miyamoto N; Kashiwagi E; Kidani A; Yokomizo A; Naito S; Kohno K
    Cancer Res; 2008 Jan; 68(1):98-105. PubMed ID: 18172301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.
    Shiota M; Izumi H; Tanimoto A; Takahashi M; Miyamoto N; Kashiwagi E; Kidani A; Hirano G; Masubuchi D; Fukunaka Y; Yasuniwa Y; Naito S; Nishizawa S; Sasaguri Y; Kohno K
    Cancer Res; 2009 Apr; 69(7):3148-56. PubMed ID: 19318582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.
    Shiota M; Yokomizo A; Itsumi M; Uchiumi T; Tada Y; Song Y; Kashiwagi E; Masubuchi D; Naito S
    BJU Int; 2011 Jul; 108(2 Pt 2):E142-9. PubMed ID: 21083641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
    Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway.
    Zhuo WL; Wang Y; Zhuo XL; Zhang YS; Chen ZT
    Biochem Biophys Res Commun; 2008 May; 369(4):1098-102. PubMed ID: 18331824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
    Zhang YW; Zhao XX; Tan C; Zhang ZG; Jiang Y; Chen JN; Wei HB; Xue L; Li HG; Du H; Shao CK
    Oncotarget; 2015 Jan; 6(1):207-20. PubMed ID: 25402957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist contributes to proliferation and epithelial-to-mesenchymal transition-induced fibrosis by regulating YB-1 in human peritoneal mesothelial cells.
    He L; Che M; Hu J; Li S; Jia Z; Lou W; Li C; Yang J; Sun S; Wang H; Chen X
    Am J Pathol; 2015 Aug; 185(8):2181-93. PubMed ID: 26055210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
    Cheng GZ; Chan J; Wang Q; Zhang W; Sun CD; Wang LH
    Cancer Res; 2007 Mar; 67(5):1979-87. PubMed ID: 17332325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.
    Shiota M; Song Y; Yokomizo A; Kiyoshima K; Tada Y; Uchino H; Uchiumi T; Inokuchi J; Oda Y; Kuroiwa K; Tatsugami K; Naito S
    Clin Cancer Res; 2010 Dec; 16(23):5654-63. PubMed ID: 21138866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of Twist and YB-1 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma].
    Li M; Guan H; Hu X; Wang Y; Wei Q; Yang Q
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):594-9. PubMed ID: 26705185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation.
    Lee HJ; Li CF; Ruan D; Powers S; Thompson PA; Frohman MA; Chan CH
    Mol Cell; 2016 Sep; 63(6):1021-33. PubMed ID: 27618486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells.
    Guay D; Garand C; Reddy S; Schmutte C; Lebel M
    Cancer Sci; 2008 Apr; 99(4):762-9. PubMed ID: 18307537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT.
    Li R; Wu C; Liang H; Zhao Y; Lin C; Zhang X; Ye C
    Int J Oncol; 2018 Oct; 53(4):1763-1773. PubMed ID: 30066890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
    Peng F; Zhang H; Du Y; Tan P
    Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling in TWIST-depleted gastric cancer cells.
    Feng MY; Wang K; Shi QT; Yu XW; Geng JS
    Anat Rec (Hoboken); 2009 Feb; 292(2):262-70. PubMed ID: 19051271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
    Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.
    Astanehe A; Finkbeiner MR; Krzywinski M; Fotovati A; Dhillon J; Berquin IM; Mills GB; Marra MA; Dunn SE
    Oncogene; 2012 Oct; 31(41):4434-46. PubMed ID: 22249268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer.
    Song YH; Shiota M; Yokomizo A; Uchiumi T; Kiyoshima K; Kuroiwa K; Oda Y; Naito S
    Urol Oncol; 2014 Jan; 32(1):31.e1-7. PubMed ID: 23395237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
    J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.